Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

49.56
-2.0750-4.02%
Volume:1.27M
Turnover:64.23M
Market Cap:7.77B
PE:59.71
High:51.24
Open:50.90
Low:49.42
Close:51.63
Loading ...

Bio-Techne Releases Third Quarter Fiscal 2025 Results

THOMSON REUTERS
·
07 May

Bio-Techne Declares Dividend and New Share Repurchase Program

THOMSON REUTERS
·
07 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 May

Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
06 May

Should You Hold Bio-Techne Corp. (TECH) For the Long Term?

Insider Monkey
·
02 May

Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
02 May

Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
30 Apr

Scaleready Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

THOMSON REUTERS
·
29 Apr

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

PR Newswire
·
29 Apr

Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
26 Apr

Bio-Techne Corporation (TECH) Slid Due to NIH’s Funding Concerns

Insider Monkey
·
24 Apr

3 Healthcare Stocks Facing Headwinds

StockStory
·
24 Apr

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
24 Apr

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

PR Newswire
·
23 Apr

G-TECH Optoelectronics to Invest Additional NT$1.39 Billion in Vietnam

MT Newswires Live
·
23 Apr

Cycurion, Inc. Announces Expansion into Latin America Through Partnership with LSV-TECH International of Colombia

GlobeNewswire
·
22 Apr

Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
22 Apr

OmniAb Announces Two New Appointments to its Board of Directors

Business Wire
·
21 Apr

Bio-Techne price target lowered to $51 from $68 at Baird

TIPRANKS
·
21 Apr

Leerink Partners Adjusts Price Target on Bio-Techne to $80 From $95, Keeps Outperform Rating

MT Newswires Live
·
17 Apr